Feds issue EMR meaningful use guidelines

The Centers for Medicare and Medicaid Services issued a 556-page proposal detailing guidelines for determining which doctors’ offices and hospitals will be eligible to tap nearly $20 billion in federal funds aimed at encouraging the use of electronic medical records.

Part of the American Recovery and Reinvestment Act passed into law last year set aside the cash for physician practices and hospitals that can show “meaningful use” of EMR technology, but didn’t spell out how such use would be determined. That left the medical industry wondering who would be eligible to collect what could amount to $40,000 per doc over the course of a few years.

The new proposal (PDF), which is open to public comment, provides some detail. But it doesn’t reveal which EMR providers will be certified under the program or explain who and how those providers will be certified.

Practices and hospitals will be able to tap the ARRA funds if they meet the following criteria:

  • “Eligible professionals” — doctors, in CMS-speak — must use “computerized physician order entry” or EMRs for at least 80 percent of all orders. Hospitals must use CPOE for at least 10 percent of orders.
  • The EP or hospital must be able to electronically check for drug-drug, drug-allergy and drug-formulary interactions to make prescribing drugs safer.
  • Eighty percent of all patients must have at least one entry in a “problem list of current and active diagnoses,” or ” an indication of none as structured data.”
  • Eligibility requires electronic prescription capability; at least 75 percent of all prescriptions must be made using an eRx system.
  • Eighty percent of all patients must have at least one eRx (or an indication of no prescription).
  • Eighty percent of all patients must have at least one entry denoting an allergy to medication (or an entry indicating no allergies).
  • At least 80 percent of all patients must have demographic data recorded (language, insurance, gender, race, ethnicity and dates of birth and death “in the event of mortality”).
  • At least 80 percent of all patients of 2 years old and older must have vital sign data recorded (height, weight, blood pressure, body mass index and growth charts for patients ages 2 to 20).
  • At least 80 percent of all patients of 13 years or older must have their smoking status recorded.
  • At least 50 percent of all patients must have their clinical lab tests recorded.
  • Eligibility requires the generation of at least one list of patients with a specific condition “to use for quality improvement, reduction of disparities and outreach.”
  • EPs and hospitals must report ambulatory quality measures.
  • Follow-up or preventive care reminders must be sent to at least 50 percent of patients aged 50 or more.
  • EPs and eligible hospitals must implement five “clinical decision support rules relevant to specialty or high clinical priority,” including diagnostics, and the ability to track compliance with the rules.
  • Insurance eligibility must be able to be checked electronically for at least 80 percent of all patients.
  • At least 80 percent of all insurance claims must be filed electronically.
  • At least 80 percent of all patients requesting electronic copies of their health records must receive them within 48 hours.
  • At least 80 percent of all patients discharged from eligible hospitals must receive electronic copies of their discharge orders if they request them.
  • “At least 10 percent of all unique patients seen by the EP are provided timely electronic access to the health information.”
  • “Clinical summaries are provided for at least 80 percent of all office visits.”
  • Eligibility requires at least one test of the EMR system’s ability to exchange clinical information with other EPs’ or hospitals’ systems.
  • “Perform medication reconciliation for at least 80 percent of relevant encounters and transitions of care.”
  • “Provide summary of care record for at least 80 percent of transitions of care and referrals.”
  • Eligibility requires at least one test of the EMR system’s ability to submit data to immunization registries.”
  • Eligibility requires at least one test of the EMR system’s ability to submit lab reports to public health agencies — unless those agencies lack the ability to receive that data electronically.
  • Eligibility requires a review of the data security of the EMR system and implementation of any security updates.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply